article
15 March 2017 | By Caleb Roberts, Francesco Gatto, Jens Nielsen, John C Waterton, Juliana Maynard, Paul D Hockings
Drug developers sometimes think of imaging as an emerging discipline. But John Waterton, Paul Hockings, Juliana Maynard and Caleb Roberts explain how imaging biomarkers are transforming drug development. Francesco Gatto and Jens Nielsen, from the Chalmers University of Technology in Sweden, discuss moving towards systems biomarkers for cancer diagnosis...